Impact of the Consumption of Tea Polyphenols on Early Atherosclerotic Lesion Formation and Intestinal Bifidobacteria in High-Fat-Fed ApoE(-/-) Mice

被引:69
作者
Liao, Zhen-Lin [1 ]
Zeng, Ben-Hua [2 ]
Wang, Wei [1 ]
Li, Gui-Hua [1 ]
Wu, Fei [1 ]
Wang, Li [1 ]
Zhong, Qing-Ping [1 ]
Wei, Hong [2 ]
Fang, Xiang [1 ]
机构
[1] South China Agr Univ, Coll Food Sci, Guangzhou, Guangdong, Peoples R China
[2] Third Mil Med Univ, Dept Lab Anim Sci, Coll Basic Med Sci, Chongqing, Peoples R China
基金
中国国家自然科学基金; 国家高技术研究发展计划(863计划);
关键词
atherosclerosis; Bifidobacteria; gut microbiome; tea polyphenols; C57BL/6 ApoE(-/-) mice;
D O I
10.3389/fnut.2016.00042
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
There is an increasing interest in the effect of dietary polyphenols on the intestinal microbiota and the possible associations between this effect and the development of some cardiovascular diseases, such as atherosclerosis (AS). However, limited information is available on how these polyphenols affect the gut microbiota and AS development. This study was designed to evaluate the modulation of dietary tea polyphenols (TPs) on intestinal Bifidobacteria (IB) and its correlation with AS development in apolipoprotein E-deficient (ApoE(-/-)) mice. Fifty C57BL/6 ApoE(-/-) mice were randomized into one of the five treatment groups (n = 10/group): control group fed normal diet (CK); a group fed a high-fat diet (HFD); and the other three groups fed the same HFD supplemented with TPs in drinking water for 16 weeks. The total cholesterol and low-density lipoprotein cholesterol (LDL-C) were decreased significantly (P < 0.05) after TP interference. In addition, the TP diet also decreased the plaque area/lumen area (PA/LA) ratios (P < 0.01) in the TP diet group. Interestingly, copies of IB in the gut of ApoE(-/-) mice were notably increased with TP interference. This increase was dose dependent (P < 0.01) and negatively correlated with the PA/LA ratio (P < 0.05). We conclude that TPs could promote the proliferation of the IB, which is partially responsible for the reduction of AS plaque induced by HFD.
引用
收藏
页数:9
相关论文
共 51 条
[1]   The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients' [J].
Atalay, G ;
Dirix, L ;
Biganzoli, L ;
Beex, L ;
Nooij, M ;
Cameron, D ;
Lohrisch, C ;
Cufer, T ;
Lobelle, JP ;
Mattiaci, MR ;
Piccart, M ;
Paridaens, R .
ANNALS OF ONCOLOGY, 2004, 15 (02) :211-217
[2]   Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota [J].
Bartosch, S ;
Fite, A ;
Macfarlane, GT ;
McMurdo, MET .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2004, 70 (06) :3575-3581
[3]   A LOW-FAT DIET DECREASES HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL LEVELS BY DECREASING HDL APOLIPOPROTEIN TRANSPORT RATES [J].
BRINTON, EA ;
EISENBERG, S ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (01) :144-151
[4]   Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism [J].
Caesar, R. ;
Fak, F. ;
Backhed, F. .
JOURNAL OF INTERNAL MEDICINE, 2010, 268 (04) :320-328
[5]   Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia [J].
Cani, P. D. ;
Neyrinck, A. M. ;
Fava, F. ;
Knauf, C. ;
Burcelin, R. G. ;
Tuohy, K. M. ;
Gibson, G. R. ;
Delzenne, N. M. .
DIABETOLOGIA, 2007, 50 (11) :2374-2383
[6]   Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice [J].
Cani, Patrice D. ;
Bibiloni, Rodrigo ;
Knauf, Claude ;
Neyrinck, Audrey M. ;
Neyrinck, Audrey M. ;
Delzenne, Nathalle M. ;
Burcelin, Remy .
DIABETES, 2008, 57 (06) :1470-1481
[7]   The Role of the Gut Microbiota in Energy Metabolism and Metabolic Disease [J].
Cani, Patrice D. ;
Delzenne, Nathalie M. .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (13) :1546-1558
[8]   Benefits of polyphenols on gut microbiota and implications in human health [J].
Cardona, Fernando ;
Andres-Lacueva, Cristina ;
Tulipani, Sara ;
Tinahones, Francisco J. ;
Isabel Queipo-Ortuno, Maria .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2013, 24 (08) :1415-1422
[9]   Influence of a probiotic soy product on fecal microbiota and its association with cardiovascular risk factors in an animal model [J].
Cavallini, Daniela C. U. ;
Suzuki, Juliana Y. ;
Abdalla, Dulcineia S. P. ;
Vendramini, Regina C. ;
Pauly-Silveira, Nadiege D. ;
Roselino, Mariana N. ;
Pinto, Roseli A. ;
Rossi, Elizeu A. .
LIPIDS IN HEALTH AND DISEASE, 2011, 10
[10]   Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease [J].
Chapman, M. John .
PHARMACOLOGY & THERAPEUTICS, 2006, 111 (03) :893-908